Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia (Q34008593)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
William G Wierda
1 reference
Michael J Keating
1 reference
Susan Lerner
1 reference
Xavier C Badoux
1 reference
Jan Burger
1 reference
Susan M O'Brien
1 reference
Xuemei Wang
1 reference
Charles Koller
1 reference
13 June 2011
1 reference
1 reference
118
1 reference
2085-2093
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference